Synthesis, Crystal Structure, and Cooperative 3d-5d Magnetism in Rock Salt Type Li4NiOsO6 and Li3Ni2OsO6.

Two new transition metal oxides with the nominal chemical compositions of Li4NiOsO6 and Li3Ni2OsO6 were successfully synthesized. Both compounds crystallize in an ordered rock salt structure type in the monoclinic C2/m space group. The crystal structures were determined using both synchrotron X-ray and time-of-flight neutron, powder diffraction data. In both phases, Ni2+ ions are present while oxidation states of osmium are +6 and +5 in Li4NiOsO6 and Li3Ni2OsO6, respectively. Ni2+ ions in the hypothetical fully ordered phase form a honeycomb arrangement in the ab crystallographic plane and these hexagons are centered by osmium ions. The magnetic layers are separated along the c axis by the octahedra, which are centered by Li+ (or Li+/Ni2+, depending on the chemical compositions). Crystal structure refinements reveal that there is some degree of mixed occupancy in cationic positions. Temperature dependent magnetic susceptibility data for both phases show ferrimagnetic transitions with predominant antiferromagnetic (AFM) interactions among 3d electrons of nickel and 5d electrons of osmium. Iso-thermal magnetization loops as a function of the applied magnetic field below the transition temperatures confirm the ferrimagnetic nature in magnetic transitions. Temperature dependent heat capacity data, however, did not exhibit any anomaly in either phase, indicating the absence of long-range magnetic ordering. The lack of long-range order for both Os5+ and Os6+-based compounds was also confirmed by low temperature neutron diffraction data down to 10 K. Temperature dependent AC magnetic susceptibility data in various frequencies for both samples indicate that Li4NiOsO6 exhibits spin-glass-like behavior, while the transition temperature for Li3Ni2OsO6 is nearly frequency independent.

Synthesis, Crystal Structure, and Magnetic Properties of the Highly Frustrated Orthorhombic Li4MgReO6.

In an effort to understand the structure-property relationship in magnetically frustrated systems, an orthorhombic analog of the S = 1/2 Re-based oxide Li4MgReO6 has been successfully synthesized and its physical properties were investigated. Li4MgReO6 had been previously synthesized in a monoclinic system in an ordered NaCl structure type. That system was shown to exhibit spin glass behavior below ∼12 K. The crystal structure of the latter phase was determined using powder X-ray diffraction data. A structural model was refined in the orthorhombic Fddd space group that resulted in cell dimensions of a = 5.84337 (7) Å, b = 8.33995 (9) Å, and c = 17.6237 (2) Å. The magnetic ions, Re6+ (S = 1/2), consist of various arrangements of interconnected triangles and trigonal prisms that offer potential for geometric magnetic frustration. Temperature dependent magnetic susceptibility reveals an AFM transition below ∼2 K along with a ZFC/FC divergence suggestive of spin freezing. The Curie-Weiss fitting parameters to the paramagnetic regime result in θ = -124 (1) K, which is indicative of predominant AFM interactions. A frustration index of ∼62 is in accordance with a highly frustrated magnetic ground state. Zero field (ZF) µSR data provides evidence for the onset of magnetic order below 4 K, along with the evidence for dynamical fluctuations up to 5 K. Moreover, longitudinal field (LF) µSR data reveals a complete decoupling in applied field at 2 K, which is indicative of static order in most or all of the volume fraction at ∼2 K, with partial ordered volumes coexisting with dynamical fluctuations up to 5 K. Estimates of the relative strengths of various magnetic exchange pathways at the level of spin-dimer analysis for this novel system are calculated and are compared to those of the previously reported values for the monoclinic analog.

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain.

BACKGROUND: Parkinson's disease (PD) is a complex, age-related neurodegenerative disorder of largely unknown etiology. PD is strongly associated with mitochondrial respiratory dysfunction, which can lead to epigenetic dysregulation and specifically altered histone acetylation. Nevertheless, and despite the emerging role of epigenetics in age-related brain disorders, the question of whether aberrant histone acetylation is involved in PD remains unresolved. METHODS: We studied fresh-frozen brain tissue from two independent cohorts of individuals with idiopathic PD (n = 28) and neurologically healthy controls (n = 21). We performed comprehensive immunoblotting to identify histone sites with altered acetylation levels in PD, followed by chromatin immunoprecipitation sequencing (ChIP-seq). RNA sequencing data from the same individuals was used to assess the impact of altered histone acetylation on gene expression. RESULTS: Immunoblotting analyses revealed increased acetylation at several histone sites in PD, with the most prominent change observed for H3K27, a marker of active promoters and enhancers. ChIP-seq analysis further indicated that H3K27 hyperacetylation in the PD brain is a genome-wide phenomenon with a strong predilection for genes implicated in the disease, including SNCA, PARK7, PRKN and MAPT. Integration of the ChIP-seq with transcriptomic data from the same individuals revealed that the correlation between promoter H3K27 acetylation and gene expression is attenuated in PD patients, suggesting that H3K27 acetylation may be decoupled from transcription in the PD brain. Strikingly, this decoupling was most pronounced among nuclear-encoded mitochondrial genes, corroborating the notion that impaired crosstalk between the nucleus and mitochondria is involved in the pathogenesis of PD. Our findings independently replicated in the two cohorts. CONCLUSIONS: Our findings strongly suggest that aberrant histone acetylation and altered transcriptional regulation are involved in the pathophysiology of PD. We demonstrate that PD-associated genes are particularly prone to epigenetic dysregulation and identify novel epigenetic signatures associated with the disease.

Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation.

Seizures have been reported in two families with myoclonus-dystonia due to epsilon-sarcoglycan (SGCE) mutations. We report a Norwegian family with myoclonus-dystonia and epilepsy associated with a novel SGCE mutation. All six manifesting SGCE mutation carriers had myoclonus, and dystonia was present in two patients. Sequencing of the SGCE gene in the proband identified a novel frameshift c.372delG mutation that predicts the amino acid change [p.Lys125SerfsX7] and the formation of a premature stop codon. The mutation segregated with myoclonus-dystonia in the family. The typical motor symptoms were accompanied by generalized seizures in four of six affected mutation carriers. The seizure type included febrile, absence and generalized tonic-clonic seizures. One deceased patient with severe epilepsy and myoclonus could not be tested for the SGCE mutation. Seizures are rarely observed in myoclonus-dystonia patients with SGCE mutations, and may not be a part of the phenotype. The co-occurrence of seizures and myoclonus-dystonia suggests that they are both due to the same underlying SGCE mutation. However, with epilepsy being a relatively common disorder and lack of complete co-segregation in our and previous families, it is possible that some patients suffer from two different genetic disorders. The presence of seizures and EEG abnormalities should not be considered exclusion criteria for the diagnosis of myoclonus-dystonia.